1. Randomized clinical trial: effect of the 5‐HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment. Issue 2 (21st December 2014) Authors: Tack, J.; Zerbib, F.; Blondeau, K.; des Varannes, S. B.; Piessevaux, H.; Borovicka, J.; Mion, F.; Fox, M.; Bredenoord, A. J.; Louis, H.; Dedrie, S.; Hoppenbrouwers, M.; Meulemans, A.; Rykx, A.; Thielemans, L.; Ruth, M. Journal: Neurogastroenterology & motility Issue: Volume 27:Issue 2(2015:Feb.) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗